Entera Bio Ltd expected to post a loss of 18  cents a share - Earnings Preview

Entera Bio

10/05/2022 13:10

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 12. 
    * The Jerusalem Israel-based   company is expected to report
 a
13.7% increase in revenue to $178.5 thousand from $157 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Entera Bio Ltd is
for a
loss of 18 cents per share. For the same quarter last year, the
company reported a loss of 11 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$6​, above​ its last closing price of $2.13. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.31       -0.23      -0.21     Beat    10
 Sep. 30 2021  -0.13       -0.11      -0.09     Beat    21.7
 Jun. 30 2021  -0.12       -0.12      -0.21     Missed  -75​
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    8.3
 ​​Dec.        -0.14       -0.14      -0.13     Beat    7.1
 31 2020                                                
 Sep. 30 2020  -0.20       -0.20      -0.09     Beat    55​
 Jun. 30 2020  -0.12       -0.12      -0.17     Missed  -41.7
 This summary was machine generated May 10 at 12:10 GMT.  All
figures in US dollars  unless otherwise stated